Vice President, Finance Planning and Analysis

About the role

Vir Bio is seeking a Vice President of Financial Planning & Analysis to lead enterprise‑wide financial planning and serve as a core member of the Company's strategic and operational leadership. This role is accountable for driving capital allocation, long‑range financial strategy, and performance management across the organization, with direct impact on enterprise value creation and strategic decision‑making. The VP, FP&A will own the Company's planning and forecasting architecture, valuation framework, and financial decision support, partnering closely with the executive team, functional leadership, and project teams. This is a highly visible, hands‑on leadership role requiring strong judgment, deep biotech financial expertise, and the ability to translate complexity into clear, actionable recommendations. This role is based in Vir's San Francisco headquarters with an expectation of at least three days per week in the office.

Responsibilities

• Lead the enterprise FP&A function, establishing short‑ and long‑term financial plans that align capital deployment with the Company's highest‑value strategic priorities
• Own company‑wide budgeting, forecasting, and long‑range planning processes, with accountability for performance against plan and recommended corrective actions
• Serve as a senior finance business partner to executive leadership, providing financial leadership on clinical development, manufacturing, partnerships, commercial and key strategic initiatives
• Partner with Accounting on collaboration and partnership financials, including quarter‑end activities, external funding applications, reporting, and partner‑facing budget management
• Maintain and continuously refine the Company's internal valuation and scenario‑modeling framework
• Lead, develop, and scale a high‑performing FP&A team responsible for portfolio investment analysis and strategic financial support for R&D
• Advance financial analytics, reporting, and systems to support executive, Board, investor, and partner decision‑making along with assisting with internal and business development valuations
• Design and implement process and reporting enhancements that improve transparency, discipline, and decision quality
• WHO YOU ARE AND WHAT YOU BRING
• Bachelor's degree in finance, accounting, or a related discipline, with fifteen or more years of progressive finance leadership experience
• MBA and/or CPA, or equivalent advanced credentials strongly preferred
• Deep experience supporting biotech or pharmaceutical R&D organizations, including development economics and portfolio decision‑making
• Demonstrated expertise in valuation, scenario modeling, and capital allocation in complex and uncertain environments
• Commercial financial planning expertise in the Biotech or Pharma industry
• Proven executive leadership skills, including building and leading teams, influencing senior stakeholders, and partnering cross‑functionally
• Strong systems orientation with experience operating sophisticated planning, forecasting, or ERP platforms
• Sound knowledge of US GAAP, internal controls, and SOX‑compliant environments
• #LI-AS1
• #LI-Onsite
• WHO WE ARE AND WHAT WE OFFER
• The expected salary range for this position is $300,000 to $350,000. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
• Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
• All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business re

Benefits

Additional Information

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN ® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology has exclusive rights to the universal PRO-XTEN ® masking platform for oncology and infectious disease. PRO-XTEN ® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company. We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at virbiotechnologyinc? Share your experience